Risk stratification of acute myeloid leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 643-645, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-667754
ABSTRACT
Patients with acute myeloid leukemia (AML) present a great heterogeneity in clinical presentation and prognosis, and adequate risk stratification before treatment is particularly important in selecting a rational treatment. In addition, a standardized dynamic minimal residual disease (MRD) analysis during treatment will improve early prediction of leukemia relapse and timely intervention. In addition to routine prognostic stratification, newly discovered molecular markers in recent years provide new effective markers for risk stratification and MRD monitoring of AML.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Etiology study
/
Prognostic study
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS